Abstract:Background: Radiation-induced lung injury (RILI) is a severe side effect of radiotherapy for non-small cell lung cancer (NSCLC) ,and one of the major hindrances to improve the efficacy of radiotherapy. Previous studies have confirmed that sodium butyrate (NaB) has potential of anti-radiation toxicity. However, the mechanism of the protective effect of NaB against RILI has not yet been clarified. This study aimed to explore the underlying protective mechanisms of NaB against RILI in NSCLC through network pharmacology, molecular docking, molecular dynamic simulations and in vivo experiments. Methods: The predictive target genes of NaB were obtained from the PharmMapper database and the literature review. The involved genes of RILI and NSCLC were predicted using OMIM and GeneCards database. The intersectional genes of drug and disease were identified using the Venny tool and uploaded to the Cytoscape software to identify 5 core target genes of NaB associated with RILI. The correlations between the 5 core target genes and EGFR, PD-L1, immune infiltrates, chemokines and chemokine receptors were analyzed using TIMER 2.0, TIMER and TISIDB databases. We constructed the mechanism maps of the 3 key signaling pathways using the KEGG database based on the results of GO and KEGG analyses from Metascape database. The 5 core target genes and drug were docked using the AutoDock Vina tool and visualized using PyMOL software. GROMACS software was used to perform 100 ns molecular dynamics simulation. Irradiation-induced lung injury model in mice were established to assess the therapeutic effects of NaB. Results: A total of 51 intersectional genes involved in NaB against RILI in NSCLC were identified. The 5 core target genes were AKT1, TP53, NOTCH1, SIRT1, and PTEN. The expressions of the 5 core target genes were significantly associated with EGFR, PD-L1, immune infiltrates, chemokines and chemokine receptors, respectively. The results from GO analysis of the 51 intersectional genes revealed that the biological processes were focused on the regulation of smooth muscle cell proliferation, oxidative stress and cell death, while the three key KEGG pathways were enriched in PI3K-Akt signal pathway, p53 signal pathway, and FOXO signal pathway. The docking of NaB with the 5 core target genes showed affinity and stability, especially AKT1. In vivo experiments showed that NaB treatment significantly protected mice from RILI, with reduced lung histological damage. In addition, NaB treatment significantly inhibited the PI3K/Akt signaling pathway. Conclusions: NaB may protect patients from RILI in NSCLC through multiple target genes including AKT1, TP53, NOTCH1, SIRT1 and PTEN, with multiple signaling pathways involving, including PI3K-Akt pathway, p53 pathway, and FOXO pathways. Our findings effectively provide a feasible theoretical basis to further elucidate the mechanism of NaB in the treatment of RILI.

Protective Effects of Berberine on Radiation-Induced Lung Injury Via Intercellular Adhesion Molecular-1 and Transforming Growth Factor-Beta-1 in Patients with Lung Cancer.

Effects of berberine against radiation-induced intestinal injury in mice.

Berberine Inhibits Acute Radiation Intestinal Syndrome in Human with Abdomen Radiotherapy.

Effects of Rhubarb Extract on Radiation Induced Lung Toxicity Via Decreasing Transforming Growth Factor-Beta-1 and Interleukin-6 in Lung Cancer Patients Treated with Radiotherapy.

Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level

Prediction of the Mechanism of Sodium Butyrate against Radiation-Induced Lung Injury in Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Dynamic Simulations and Molecular Dynamic Simulations

Radiosensitization Effects of Berberine on Human Breast Cancer Cells.

Analysis Of Clinical And Dosimetric Factors Influencing Radiation-Induced Lung Injury In Patients With Lung Cancer

Polydatin Alleviated Radiation-Induced Lung Injury Through Activation of Sirt3 and Inhibition of Epithelial-Mesenchymal Transition.

Grape Seed Pro-Anthocyanidins Ameliorates Radiation-Induced Lung Injury

Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications

Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons.

Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review

Modulation of Radiation-Induced Tumour Necrosis Factor-Α and Transforming Growth Factor Β1 Expression in the Lung Tissue by Shengqi Fuzheng Injection.

Epithelial-to-mesenchymal Transition Markers to Predict Response of Berberine in Suppressing Lung Cancer Invasion and Metastasis

Multidimensional screening of Astragalus membranaceus small molecules to mitigate carbon ion radiation-induced bystander effects

Effects of Irradiation with Different Fractionations on Radioresistant Esophageal Cancer Cells and Lung Tissues

Effects of Berberine on the Proliferation of Human Pulmonary Carcinoma Cells

Analysis of Predictive Factors of Radiation Induced Lung Injury in Patients Treated with Chemoradiotherapy with Lung Cancer.

Berberine Suppresses Lung Metastasis of Cancer Via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1.

Protective effect of melatonin entrapped PLGA nanoparticles on radiation-induced lung injury through the miR-21/TGF-β1/Smad3 pathway